Lv1
36 积分 2022-03-28 加入
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
20小时前
待确认
B cell antigens: A key to optimizing CAR-T cell therapy
23天前
已完结
Amplifying antigen-induced cellular responses with proximity labelling
23天前
已完结
Study of the dynamic changes in the non-volatile chemical constituents of black tea during fermentation processing by a non-targeted metabolomics approach
24天前
已完结
Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates
1个月前
已完结
Design of KYSA-6, a Phase 2, Open-label, Multicenter Study of KYV-101, a Novel Fully Human Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Refractory Generalized Myasthenia Gravis (P7-11.034)
1个月前
已关闭
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity
1个月前
已完结
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology
1个月前
已完结
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
1个月前
已完结
Anti-BCMA CAR-T therapy in patients with progressive multiple sclerosis
1个月前
已完结
皖公网安备34019202002308
